Skip to main content
Erschienen in: Pediatric Radiology 1/2019

28.09.2018 | Original Article

Contrast-enhanced ultrasound in the diagnosis of pediatric focal nodular hyperplasia and hepatic adenoma: interobserver reliability

verfasst von: Cheng Fang, Silvia Bernardo, Maria E. Sellars, Annamaria Deganello, Paul S. Sidhu

Erschienen in: Pediatric Radiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Focal nodular hyperplasia and hepatic adenoma are rare liver tumors in which specific features on contrast-enhanced ultrasound (US) have been reported but are little known in children.

Objective

To assess the interobserver agreement in diagnosing and differentiating focal nodular hyperplasia and hepatic adenoma in children using established adult contrast-enhanced US characteristics.

Materials and methods

Thirty children with a definite or probable diagnosis of focal nodular hyperplasia or hepatic adenoma on magnetic resonance imaging (MRI)/histology who underwent contrast-enhanced US studies were included. Typical and additional contrast-enhanced US features of focal nodular hyperplasia and hepatic adenoma were included. The lesions were classified as definite/probable focal nodular hyperplasia, definite/probably hepatic adenoma or unclassified. The interobserver kappa of contrast-enhanced US characteristics was calculated.

Results

Focal nodular hyperplasia and hepatic adenoma in children demonstrate contrast-enhanced US characteristics similar to those in adults. Among the nine lesions with confirmed histological diagnosis, correct diagnosis was made in 7 (77.8%) based on contrast-enhanced US criteria. Two lesions were unclassified by both observers due to a mixed arterial filling pattern. Interobserver kappa for contrast-enhanced US diagnosis was 0.64 (P<0.0001).

Conclusion

There is a good interobserver kappa for separating focal nodular hyperplasia from hepatic adenoma in children using established adult contrast-enhanced US features.
Literatur
1.
Zurück zum Zitat Chiorean L, Cui XW, Tannapfel A et al (2015) Benign liver tumors in pediatric patients - review with emphasis on imaging features. World J Gastroenterol 21:8541–8561CrossRefPubMedPubMedCentral Chiorean L, Cui XW, Tannapfel A et al (2015) Benign liver tumors in pediatric patients - review with emphasis on imaging features. World J Gastroenterol 21:8541–8561CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat European Association for the Study of the Liver (EASL) (2016) EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol 65:386–398CrossRef European Association for the Study of the Liver (EASL) (2016) EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol 65:386–398CrossRef
3.
Zurück zum Zitat Scheimann AO, Barrios JM, Al-Tawil YS et al (2000) Percutaneous liver biopsy in children: impact of ultrasonography and spring-loaded biopsy needles. J Pediatr Gastroenterol Nutr 31:536–539CrossRefPubMed Scheimann AO, Barrios JM, Al-Tawil YS et al (2000) Percutaneous liver biopsy in children: impact of ultrasonography and spring-loaded biopsy needles. J Pediatr Gastroenterol Nutr 31:536–539CrossRefPubMed
4.
Zurück zum Zitat Tselikas L, Pigneur F, Roux M et al (2017) Impact of hepatobiliary phase liver MRI versus contrast-enhanced ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors. Abdom Radiol (NY) 42:825–832CrossRef Tselikas L, Pigneur F, Roux M et al (2017) Impact of hepatobiliary phase liver MRI versus contrast-enhanced ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors. Abdom Radiol (NY) 42:825–832CrossRef
5.
Zurück zum Zitat Kolbe AB, Podberesky DJ, Zhang B, Towbin AJ (2015) The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion. Pediatr Radiol 45:354–365CrossRefPubMed Kolbe AB, Podberesky DJ, Zhang B, Towbin AJ (2015) The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion. Pediatr Radiol 45:354–365CrossRefPubMed
7.
Zurück zum Zitat Piscaglia F, Bolondi L, Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32:1369–1375CrossRefPubMed Piscaglia F, Bolondi L, Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32:1369–1375CrossRefPubMed
8.
Zurück zum Zitat Sidhu PS, Cantisani V, Deganello A et al (2017) Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med 38:33–43PubMed Sidhu PS, Cantisani V, Deganello A et al (2017) Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med 38:33–43PubMed
9.
Zurück zum Zitat Yusuf GT, Sellars ME, Deganello A et al (2017) Retrospective analysis of the safety and cost implications of pediatric contrast-enhanced ultrasound at a single center. AJR Am J Roentgenol 208:446–452CrossRefPubMed Yusuf GT, Sellars ME, Deganello A et al (2017) Retrospective analysis of the safety and cost implications of pediatric contrast-enhanced ultrasound at a single center. AJR Am J Roentgenol 208:446–452CrossRefPubMed
10.
Zurück zum Zitat Claudon M, Dietrich CF, Choi BI et al (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39:187–210CrossRefPubMed Claudon M, Dietrich CF, Choi BI et al (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39:187–210CrossRefPubMed
11.
Zurück zum Zitat Dietrich CF (2012) Liver tumor characterization--comments and illustrations regarding guidelines. Ultraschall Med 33:S22–S30CrossRefPubMed Dietrich CF (2012) Liver tumor characterization--comments and illustrations regarding guidelines. Ultraschall Med 33:S22–S30CrossRefPubMed
12.
Zurück zum Zitat Ungermann L, Eliás P, Zizka J et al (2007) Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol 63:290–294CrossRefPubMed Ungermann L, Eliás P, Zizka J et al (2007) Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol 63:290–294CrossRefPubMed
13.
Zurück zum Zitat Roche V, Pigneur F, Tselikas L et al (2015) Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence. Eur Radiol 25:186–195CrossRefPubMed Roche V, Pigneur F, Tselikas L et al (2015) Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence. Eur Radiol 25:186–195CrossRefPubMed
14.
Zurück zum Zitat Jacob J, Deganello A, Sellars ME et al (2013) Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall Med 34:529–540CrossRefPubMed Jacob J, Deganello A, Sellars ME et al (2013) Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall Med 34:529–540CrossRefPubMed
15.
Zurück zum Zitat Pschierer K, Grothues D, Rennert J et al (2015) Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies. Clin Hemorheol Microcirc 61:333–345CrossRefPubMed Pschierer K, Grothues D, Rennert J et al (2015) Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies. Clin Hemorheol Microcirc 61:333–345CrossRefPubMed
17.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef
18.
Zurück zum Zitat Quaia E, Calliada F, Bertolotto M et al (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420–430CrossRefPubMed Quaia E, Calliada F, Bertolotto M et al (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420–430CrossRefPubMed
19.
Zurück zum Zitat Friedrich-Rust M, Klopffleisch T, Nierhoff J et al (2013) Contrast-enhanced ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver Int 33:739–755CrossRefPubMed Friedrich-Rust M, Klopffleisch T, Nierhoff J et al (2013) Contrast-enhanced ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver Int 33:739–755CrossRefPubMed
20.
Zurück zum Zitat Strobel D, Seitz K, Blank W et al (2009) Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 30:376–382CrossRefPubMed Strobel D, Seitz K, Blank W et al (2009) Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 30:376–382CrossRefPubMed
21.
Zurück zum Zitat Cha DI, Yoo S-Y, Kim JH et al (2014) Clinical and imaging features of focal nodular hyperplasia in children. AJR Am J Roentgenol 202:960–965CrossRefPubMed Cha DI, Yoo S-Y, Kim JH et al (2014) Clinical and imaging features of focal nodular hyperplasia in children. AJR Am J Roentgenol 202:960–965CrossRefPubMed
22.
Zurück zum Zitat Towbin AJ, Luo GG, Yin H, Mo JQ (2011) Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol 41:341–349CrossRefPubMed Towbin AJ, Luo GG, Yin H, Mo JQ (2011) Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol 41:341–349CrossRefPubMed
23.
Zurück zum Zitat Bouyn CI-D, Leclere J, Raimondo G et al (2003) Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 97:3107–3113CrossRefPubMed Bouyn CI-D, Leclere J, Raimondo G et al (2003) Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 97:3107–3113CrossRefPubMed
24.
Zurück zum Zitat Kong WT, Wang WP, Huang BJ et al (2015) Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma. Ultrasound Med Biol 41:944–951CrossRefPubMed Kong WT, Wang WP, Huang BJ et al (2015) Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma. Ultrasound Med Biol 41:944–951CrossRefPubMed
25.
Zurück zum Zitat Kim TK, Jang HJ, Burns PN et al (2008) Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 190:58–66CrossRefPubMed Kim TK, Jang HJ, Burns PN et al (2008) Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 190:58–66CrossRefPubMed
26.
Zurück zum Zitat Bertin C, Egels S, Wagner M et al (2014) Contrast-enhanced ultrasound of focal nodular hyperplasia: a matter of size. Eur Radiol 24:2561–2571CrossRefPubMed Bertin C, Egels S, Wagner M et al (2014) Contrast-enhanced ultrasound of focal nodular hyperplasia: a matter of size. Eur Radiol 24:2561–2571CrossRefPubMed
27.
Zurück zum Zitat Bartolotta TV, Taibbi A, Matranga D et al (2010) Hepatic focal nodular hyperplasia: contrast-enhanced ultrasound findings with emphasis on lesion size, depth and liver echogenicity. Eur Radiol 20:2248–2256CrossRefPubMed Bartolotta TV, Taibbi A, Matranga D et al (2010) Hepatic focal nodular hyperplasia: contrast-enhanced ultrasound findings with emphasis on lesion size, depth and liver echogenicity. Eur Radiol 20:2248–2256CrossRefPubMed
28.
Zurück zum Zitat Taimr P, Bröker MEE, Dwarkasing RS et al (2017) A model-based prediction of the probability of hepatocellular adenoma and focal nodular hyperplasia based on characteristics on contrast-enhanced ultrasound. Ultrasound Med Biol 43:2144–2150CrossRefPubMed Taimr P, Bröker MEE, Dwarkasing RS et al (2017) A model-based prediction of the probability of hepatocellular adenoma and focal nodular hyperplasia based on characteristics on contrast-enhanced ultrasound. Ultrasound Med Biol 43:2144–2150CrossRefPubMed
29.
Zurück zum Zitat Dietrich CF, Schuessler G, Trojan J et al (2005) Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 78:704–707CrossRefPubMed Dietrich CF, Schuessler G, Trojan J et al (2005) Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 78:704–707CrossRefPubMed
30.
Zurück zum Zitat Tamrazi A, Vasanawala SS (2011) Functional hepatobiliary MR imaging in children. Pediatr Radiol 41:1250–1258CrossRefPubMed Tamrazi A, Vasanawala SS (2011) Functional hepatobiliary MR imaging in children. Pediatr Radiol 41:1250–1258CrossRefPubMed
31.
Zurück zum Zitat Geller J, Kasahara M, Martinez M et al (2016) Safety and efficacy of gadoxetate disodium–enhanced liver MRI in pediatric patients aged >2 months to <18 years—results of a retrospective, multicenter study. Magn Reson Insights 9:21–28PubMedPubMedCentral Geller J, Kasahara M, Martinez M et al (2016) Safety and efficacy of gadoxetate disodium–enhanced liver MRI in pediatric patients aged >2 months to <18 years—results of a retrospective, multicenter study. Magn Reson Insights 9:21–28PubMedPubMedCentral
Metadaten
Titel
Contrast-enhanced ultrasound in the diagnosis of pediatric focal nodular hyperplasia and hepatic adenoma: interobserver reliability
verfasst von
Cheng Fang
Silvia Bernardo
Maria E. Sellars
Annamaria Deganello
Paul S. Sidhu
Publikationsdatum
28.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 1/2019
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-018-4250-5

Weitere Artikel der Ausgabe 1/2019

Pediatric Radiology 1/2019 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.